Tocolysis and Neurodevelopment of Children Born Very Preterm

Area of Science:

• Neonatal Medicine
• Developmental Pediatrics
• Pharmacology

Background:

• Neurodevelopmental outcomes for very preterm infants exposed to tocolytic medications are not well-established.
• Understanding the long-term effects of tocolysis is crucial for optimizing care for preterm infants.

Purpose of the Study:

• To determine if tocolysis during spontaneous preterm labor is linked to neurodevelopmental outcomes at 5.5 years.
• To assess if different types of tocolytic drugs (atosiban vs. calcium channel blockers) influence these outcomes.

Main Methods:

• A prospective, national, population-based cohort study in France.
• Included children born between 24 to 31 weeks gestation following spontaneous preterm labor without infection.
• Neurodevelopmental disabilities assessed at 5.5 years, including cerebral palsy, sensory deficits, cognitive, and behavioral issues.

Main Results:

• No significant difference in neurodevelopmental disabilities was found between preterm children exposed and not exposed to tocolytics (RR, 1.11; 95% CI, 0.85-1.45).
• Comparison of specific tocolytics showed no difference in outcomes between atosiban and calcium channel blockers (RR, 0.94; 95% CI, 0.67-1.32).
• The study analyzed data from 1320 children born to 1055 mothers.

Conclusions:

• Tocolytic treatment following spontaneous preterm labor was not associated with neurodevelopmental disabilities in very preterm children at 5.5 years.
• The type of tocolytic drug used did not appear to influence neurodevelopmental outcomes.
• These findings suggest that tocolysis does not adversely affect long-term neurodevelopment in this population.